Shareholders Equity: The sum of preferred and common equity items.
PDS Biotechnology Corporation (PDSB) had Shareholders Equity of $26.13M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-42.94M |
|
-- |
|
-- |
|
$43.05M |
|
$-43.05M |
|
$-1.30M |
|
$-44.35M |
|
$-44.35M |
|
$-42.94M |
|
$-42.94M |
|
$-42.94M |
|
$-42.94M |
|
$-43.05M |
|
$-42.34M |
|
30.95M |
|
30.95M |
|
$-1.39 |
|
$-1.39 |
|
| Balance Sheet Financials | |
$59.06M |
|
$0.13M |
|
$0.34M |
|
$59.39M |
|
$13.63M |
|
$19.63M |
|
$19.63M |
|
$33.26M |
|
$26.13M |
|
$26.13M |
|
|
Shareholders Equity |
$26.13M |
33.09M |
|
| Cash Flow Statement Financials | |
$-33.64M |
|
-- |
|
$16.38M |
|
$73.82M |
|
$56.56M |
|
$-17.26M |
|
$7.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.33 |
|
-- |
|
-- |
|
0.43 |
|
0.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-33.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-164.33% |
|
-164.33% |
|
-72.31% |
|
-93.84% |
|
$0.79 |
|
$-1.09 |
|
$-1.09 |
|